Clinical Pharmacists and Health Coaches Improve Diabetes Management

By Staff Writer

October 4, 2023

A Collaborative Approach to Diabetes Care

A recent study has shown that clinical pharmacists, in collaboration with health coaches, are making a significant impact on diabetes management and cardiovascular disease risk reduction. They provide comprehensive medication management, addressing adverse effects and drug interactions, assisting in medication taking, and intensifying therapy. The study also highlighted the importance of collaborative action with physicians in improving patient outcomes.

Innovative Methods for Effective Diabetes Management

The study deployed innovative methods to achieve effective diabetes management. Patients were enrolled from primary care clinics within the University of Illinois Hospital. The inclusion criteria ensured that the study targeted African American or Latinx ethnicity, aged between 21 and 75 years, who had been receiving primary care at the clinical site for at least a year. The study utilized mobile health technologies such as telehealth and text messaging to facilitate communication between pharmacists, health coaches, and patients. Pharmacists provided medication management services remotely via videoconferencing, which was facilitated by health coaches using an internet-enabled computer tablet.

Significant Reduction in HbA1c Levels

The results of the study were promising, demonstrating a significant reduction in HbA1c levels among the patients involved. The clinical pharmacist and health coach–delivered mHealth intervention resulted in an HbA1c reduction of 0.79 percentage points. This improvement was not only significant but also sustained, with improvements maintained at 24 months. This indicates that the mHealth-driven intervention is an effective approach to improving blood glucose management. The study’s findings suggest that this strategy may be effective in reducing racial and ethnic disparities in diabetes management.

mHealth Enhances Diabetes Management

The study further demonstrated how mobile health (mHealth), including telehealth and text messaging, can enhance the activities of both pharmacists and health coaches. Pharmacists have used videoconferencing in chronic disease management to improve health care access. This approach may be more effective than text messaging support alone, which has not shown improvement in HbA1c beyond a short duration.

The study concluded that a clinical pharmacist and health coach–delivered mHealth intervention improved HbA1c levels in African American and Latinx patients with T2D over one year compared with usual diabetes care. These improvements sustained themselves at 24 months. Considering this mHealth driven intervention as an effective approach to improve blood glucose management in racial and ethnic minority patients with primary care access in urban environments may be beneficial.

Reference url

Recent Posts

access to medicines
         

Quantifying EU Medicine Access Challenges

🔍 Are we creating a healthcare system that truly works for everyone?

Recent findings from EFPIA shed light on alarming inequities in access to medicines across Europe, showing that only 46% of approved drugs are available to patients this year. With significant delays affecting smaller markets and critical cancer treatments, this article explores the systemic barriers at play and innovative solutions proposed to ensure fair access.

Dive into the full article to uncover how we can collectively shape a more equitable healthcare landscape.

#SyenzaNews #healthcare #MarketAccess

UK Medicine Payment Rates
      

Revitalizing Innovation: The Impact of UK Medicine Payment Rates

💡 Are the UK’s medicine payment rates stifling innovation in life sciences?

Recent analysis reveals that the staggering 23.5% payment rate for pharmaceuticals is not just limiting NHS spending but also curtailing R&D investments, delaying new drug launches, and threatening workforce stability. If we can lower these rates to below 10%, we could unleash significant growth and restore the UK’s competitive edge in the global life sciences landscape.

Discover the critical insights and recommendations that could reshape the future of healthcare in the UK.

#SyenzaNews #healthcarepolicy #innovation

Blinatumomab benefit assessment
            

Blinatumomab Benefit Assessment for ALL and Health Economics

🚀 How does a groundbreaking therapy change the landscape of acute lymphoblastic leukemia treatment?

The recent benefit assessment of Blinatumomab by the German Federal Joint Committee reveals critical insights into its potential as a consolidation therapy for adults with Philadelphia chromosome-negative B-cell precursor ALL. With its orphan drug status promising automatic benefits, the article explores the implications of its high cost and economic impacts, shedding light on the balance needed between innovation and sustainability in healthcare.

Jump into the full analysis to understand how this could impact clinical practice and health economics.

#SyenzaNews #HealthEconomics #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.